dactinomycin has been researched along with Acute Porphyria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, K; Gomi, Y; Mikami, Y; Nagai, T; Saito, M; Seki, H; Takai, Y | 1 |
| Bonkovsky, HL; Donohue, SE; Lambrecht, RW; Shan, Y; Zheng, J | 1 |
2 other study(ies) available for dactinomycin and Acute Porphyria
| Article | Year |
|---|---|
Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Drug Eruptions; Female; Humans; Hydatidiform Mole, Invasive; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Porphyria, Acute Intermittent; Pregnancy; Treatment Outcome; Uterine Neoplasms | 2016 |
Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
Topics: 5-Aminolevulinate Synthetase; Cell Line, Tumor; Cycloheximide; Dactinomycin; Down-Regulation; Gene Expression Regulation, Enzymologic; Half-Life; Heme; Hepatocytes; Humans; Mitochondrial Proteins; Nucleic Acid Synthesis Inhibitors; Porphyria, Acute Intermittent; Protein Synthesis Inhibitors; Protoporphyrins; RNA, Messenger | 2008 |